German pharmaceutical giant Boehringer Ingelheim is the latest company to sue the U.S. government over Medicare price negotiations under the Inflation Reduction Act. The lawsuit, filed late last week in federal court in Connecticut, contends that the act violates the First, Fifth and Eighth Amendments by taking the company’s property without due process and fair compensation, imposing excessive fines and compelling its speech.

Merck, Bristol Myers Squibb, Johnson & Johnson’s Janssen, Astellas and PhRMA have filed similar lawsuits. In July, the U.S. Chamber of Commerce filed a motion for a preliminary injunction against the program, claiming it would inflict “irreparable harm” on U.S. businesses and patients.

The Centers for Medicare & Medicaid Services is set to announce the first 10 drugs eligible for negotiation by September 1. After that, the manufacturers of these drugs will have one month to sign agreements to participate in the negotiations. The Boehringer Ingelheim diabetes drug Jardiance, developed in partnership with Eli Lily, is likely to make the list, the company said in court documents. Boehringer Ingelheim argued the negotiations would cause “serious, irreparable harm” to both the company and patients.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.